IRISanRaf

STOCCHI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.767
AS - Asia 4.203
EU - Europa 809
SA - Sud America 255
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 33
OC - Oceania 20
Totale 12.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.938
TR - Turchia 2.044
SG - Singapore 993
CN - Cina 904
CA - Canada 789
IT - Italia 250
BR - Brasile 221
DE - Germania 127
EU - Europa 110
IE - Irlanda 77
GB - Regno Unito 74
UA - Ucraina 53
VN - Vietnam 48
IN - India 44
HK - Hong Kong 41
RU - Federazione Russa 33
JP - Giappone 30
FI - Finlandia 28
MX - Messico 26
BD - Bangladesh 24
FR - Francia 23
PL - Polonia 23
NL - Olanda 22
SE - Svezia 18
AR - Argentina 15
KR - Corea 15
ES - Italia 14
AU - Australia 12
GR - Grecia 12
ZA - Sudafrica 12
LT - Lituania 11
DK - Danimarca 9
EC - Ecuador 9
EG - Egitto 9
RO - Romania 8
IL - Israele 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
KE - Kenya 6
NZ - Nuova Zelanda 6
SI - Slovenia 6
CH - Svizzera 5
ID - Indonesia 4
JO - Giordania 4
PK - Pakistan 4
SA - Arabia Saudita 4
TH - Thailandia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CO - Colombia 3
JM - Giamaica 3
KZ - Kazakistan 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BB - Barbados 2
CZ - Repubblica Ceca 2
HN - Honduras 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
TW - Taiwan 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GF - Guiana Francese 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LU - Lussemburgo 1
MA - Marocco 1
MG - Madagascar 1
MK - Macedonia 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
Totale 12.197
Salva come PNG Salva come JPEG
Città #
Kocaeli 1.743
San Mateo 1.283
Toronto 753
Dallas 684
Chandler 392
Houston 382
Santa Clara 375
Wilmington 373
Singapore 325
Lawrence 249
Princeton 249
Ashburn 214
Beijing 213
Fairfield 151
Los Angeles 112
Woodbridge 88
Seattle 80
Shanghai 69
Guangzhou 61
Rome 46
Hong Kong 39
Shenzhen 34
Cambridge 33
Munich 32
São Paulo 32
Dublin 30
Brooklyn 27
New York 27
Milan 24
Boston 20
Ho Chi Minh City 19
Tokyo 19
Warsaw 19
Wuhan 19
Helsinki 18
Jiaxing 18
Rui'an 18
Council Bluffs 17
Assago 16
Boardman 15
Montreal 15
San Francisco 15
Hanoi 14
Mexico City 14
Chennai 13
Stockholm 13
Chicago 12
Frankfurt am Main 12
London 12
The Dalles 12
Xi'an 11
Belo Horizonte 10
Quanzhou 10
Phoenix 9
Redwood City 9
Washington 9
Wuxi 9
Xuzhou 9
Denver 8
Johannesburg 8
Pune 8
West Jordan 8
Amsterdam 7
Andover 7
Ankara 7
Manchester 7
Nanjing 7
Poplar 7
Redmond 7
Rio de Janeiro 7
Solagna 7
St Petersburg 7
Ar Riyāḑ 6
Dhaka 6
Ghent 6
Kyiv 6
Nairobi 6
Naples 6
Timisoara 6
Turku 6
Atlanta 5
Dongyang 5
Florence 5
Melbourne 5
Moscow 5
Mumbai 5
Rockville 5
Salvador 5
Seoul 5
Amman 4
Auckland 4
Austin 4
Bologna 4
Chiang Mai 4
Clifton 4
Columbus 4
Curitiba 4
Guayaquil 4
Hải Dương 4
Incheon 4
Totale 8.765
Salva come PNG Salva come JPEG
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 112
Morbo di Parkinson: strategie terapeutiche e qualità della vita del malato 100
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on qualità of life in Parkinson’s disease 82
A pharmacological study of dopaminergic receptors in planaria 75
L’alimentazione del paziente parkinsoniano 71
Apomorphine and lisuride infusion. A comparative chronic study 69
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease 64
Gastrointestinal dysfunction in Parkinson's disease 63
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor 63
Analyzing gait variability and dual-task interference in patients with Parkinson's disease and freezing by means of the word-color Stroop test 63
Side-effects of subcutaneous apomorphine in Parkinson's disease 62
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 62
Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study 62
Modification of respiratory function parameters in patients with severe Parkinson's disease 61
A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm 61
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease 61
Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease 60
Neuroprotection in Parkinson's disease: clinical trials 60
Adherence to antiparkinson medication in a multicenter European study 59
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 59
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 59
A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need 58
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia 58
One year treatment with lisuride delivery pump in Parkinson's disease 57
Robot-assisted gait training versus treadmill training in patients with Parkinson's disease: a kinematic evaluation with gait profile score Epub 2016 55
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients 55
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics 54
A pharmacological study of cocaine activity in planaria 54
Physical activity and neurotrophic factors as potential drivers of neuroplasticity in Parkinson’s disease: a systematic review and meta-analysis 53
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives 53
Management of gastrointestinal alterations in Parkinson's disease 53
Case Study 10 53
Transient left bundle branch block following intravenous lisuride bolus 53
A double-blind, delayed-start trial of rasagiline in Parkinson’s disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes 53
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson disease 53
Urodynamic study in the differential diagnosis between multiple system atrophy and Parkinson's disease 53
Clinical Experiences With Levodopa Methylester (Melevodopa) in Patients With Parkinson Disease Experiencing Motor Fluctuations: An Open-Label Observational Study 53
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group 53
Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations 52
Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease 52
Managing the critical problems of advanced Parkinson's disease 52
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease 52
Unusual cardiovascular response to intravenous lisuride bolus. Possible drug-induced coronary angiospasm 52
Use of Apomorphine in Parkinson’s Disease 52
Transient atrial fibrillation after subcutaneous apomorphine bolus 52
Conventional Treatment-related Motor Complications: Their Prevention and Treatment 52
The coefficient of friction in Parkinson's disease gait 52
Jejunal delivery of levodopa methyl ester 51
Antagonist effect of terguride in Parkinson's disease 51
Levodopa: A new look at an old friend 51
The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease 51
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 51
Multicenter trial of L-Deprenyl in Parkinson disease 50
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations 50
Combination of two different dopamine agonists in the management of Parkinson's disease 50
White matter disease (Binswanger's encephalopathy) in chronic cerebrovascular disorders 50
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism 50
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 50
Parkinson's Disease: Non-motor and non-dopaminergic Features 49
Instrumental diagnosis of multiple system atrophy 49
Constipation in Parkinson's Disease 49
The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease 49
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease 49
Comparison between L-dopa and lisuride intravenous infusions: a clinical study 49
Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results 49
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary report 48
On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation 48
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease 48
Novel parkin mutations detected in patients with early-onset Parkinson's disease 48
Repeated levodopa infusions in fluctuating Parkinson's disease: clinical and pharmacokinetic data 48
Emergencies in Parkinson's disease 47
Effects of terguride in patients with Huntington's disease 47
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease 47
Motor fluctuations in levodopa treatment: clinical pharmacology 47
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder 47
Alterations of thermoregulation in Parkinson's disease 47
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 47
Continuous dopamine-receptor stimulation in advanced Parkinson's disease 47
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 47
A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease 47
A novel summary kinematic index for postural characterization in subjects with Parkinson's disease 46
Malattie Extrapiramidali: aspetti clinici e terapeutici nelle sindromi parkinsoniane 46
Validation of the freezing of gait questionnaire in patients with Parkinson's disease 46
The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson’s disease 46
GIGYF2 mutations are not frequent cause of familiar Parkinson’s disease 46
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease 46
Timed Up and Go test and wearable inertial sensor: a new combining tool to assess change in subject with Parkinson’s disease after automated mechanical peripheral stimulation treatment 46
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment 46
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies 45
Obstacles to the development of a neuroprotective therapy for Parkinson's disease 45
Comparison of IPX066 with carbidopa-levodopa plus entacapone in advanced PD patients 45
Wearing-off scales in Parkinson's disease: Critique and recommendations 45
trategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias 45
Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy 45
Dual dopamine agonist treatment in Parkinson's disease 45
Prevention and treatment of motor fluctuations 45
Clinica Neurologica 45
Gastrointestinal, urological, and sleep problems in parkinson's disease 44
Low dose of clozapine in the treatment of dopaminergic psychosis in Parkinson's disease 44
Transient cardiac arrest during continuous intravenous infusion of apomorphine 44
Totale 5.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.359 0 0 0 0 44 170 83 39 63 47 1.746 167
2021/20222.486 11 761 758 9 6 1 209 281 18 351 6 75
2022/20231.298 561 35 12 118 83 31 2 86 93 113 160 4
2023/20241.031 4 19 81 243 50 45 15 60 13 87 26 388
2024/20252.630 127 591 159 126 95 387 118 185 389 24 90 339
2025/20261.711 499 553 387 263 9 0 0 0 0 0 0 0
Totale 12.605